Related Experiment Video
Updated: Nov 14, 2025
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
SOCS-1 inhibition of type I interferon restrains Staphylococcus aureus skin host defense
Nathan Klopfenstein1,2,3, Stephanie L Brandt4, Sydney Castellanos4
1Department of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Abstract:
The skin innate immune response to methicillin-resistant Staphylococcus aureus (MRSA) culminates in the formation of an abscess to prevent bacterial spread and tissue damage. Pathogen recognition receptors (PRRs) dictate the balance between microbial control and injury. Therefore, intracellular brakes are of fundamental importance to tune the appropriate host defense while inducing resolution. The intracellular inhibitor suppressor of cytokine signaling 1 (SOCS-1), a known JAK/STAT inhibitor, prevents the expression and actions of PRR adaptors and downstream effectors. Whether SOCS-1 is a molecular component of skin host defense remains to be determined. We hypothesized that SOCS-1 decreases type I interferon production and IFNAR-mediated antimicrobial effector functions, limiting the inflammatory response during skin infection. Our data show that MRSA skin infection enhances SOCS-1 expression, and both SOCS-1 inhibitor peptide-treated and myeloid-specific SOCS-1 deficient mice display decreased lesion size, bacterial loads, and increased abscess thickness when compared to wild-type mice treated with the scrambled peptide control. SOCS-1 deletion/inhibition increases phagocytosis and bacterial killing, dependent on nitric oxide release. SOCS-1 inhibition also increases the levels of type I and type II interferon levels in vivo. IFNAR deletion and antibody blockage abolished the beneficial effects of SOCS-1 inhibition in vivo. Notably, we unveiled that hyperglycemia triggers aberrant SOCS-1 expression that correlates with decreased overall IFN signatures in the infected skin. SOCS-1 inhibition restores skin host defense in the highly susceptible hyperglycemic mice. Overall, these data demonstrate a role for SOCS-1-mediated type I interferon actions in host defense and inflammation during MRSA skin infection.
Insights
Suppressor of cytokine signaling 1 (SOCS-1) limits the skin
Area of Science:
- Immunology
- Dermatology
- Microbiology
Background:
- The skin's innate immune response to MRSA involves abscess formation to control bacterial spread.
- Pathogen recognition receptors (PRRs) regulate the balance between microbial defense and tissue injury.
- Intracellular regulators are crucial for modulating host defense and promoting resolution.
Purpose of the Study:
- To investigate the role of suppressor of cytokine signaling 1 (SOCS-1) in skin host defense against MRSA.
- To determine if SOCS-1 inhibition enhances antimicrobial responses and reduces inflammation.
- To explore the impact of hyperglycemia on SOCS-1 expression and skin infection outcomes.
Main Methods:
- MRSA skin infection model in mice.
- Treatment with SOCS-1 inhibitor peptide or genetic deletion of SOCS-1 in myeloid cells.
- Assessment of lesion size, bacterial load, abscess thickness, phagocytosis, and nitric oxide release.
- Analysis of type I and type II interferon levels.
- Interferon-alpha/beta receptor (IFNAR) deletion and antibody blockade experiments.
- Evaluation of SOCS-1 expression and host defense in hyperglycemic mice.
Main Results:
- MRSA infection increased SOCS-1 expression in the skin.
- SOCS-1 inhibition or deficiency reduced lesion size and bacterial burden, while increasing abscess thickness.
- SOCS-1 inhibition enhanced phagocytosis and bacterial killing, mediated by nitric oxide.
- SOCS-1 inhibition elevated type I and type II interferon levels, which were crucial for the observed protective effects.
- Hyperglycemia exacerbated MRSA skin infection by increasing SOCS-1 expression and reducing interferon signaling.
- SOCS-1 inhibition restored host defense in hyperglycemic mice.
Conclusions:
- SOCS-1 plays a critical role in limiting skin host defense against MRSA by suppressing type I interferon responses.
- Inhibiting SOCS-1 enhances antimicrobial immunity and reduces inflammation during MRSA skin infections.
- Targeting SOCS-1 represents a potential therapeutic strategy for managing MRSA skin infections, particularly in conditions like hyperglycemia.
Related Concept Videos
01:28Gene Regulation in Microbial Communities: Quorum Sensing
01:26Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
01:31Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:20The JAK-STAT Signaling Pathway
01:24T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...